Explore

Rapid Read Rapid Read
Global Study Develops Framework to Optimize Antibiotic Use by Country

Global Study Develops Framework to Optimize Antibiotic Use by Country

A groundbreaking international study has developed the first framework to estimate the optimal antibiotic needs for countries worldwide. Published in The Lancet Public Health, the study categorizes antibiotics into 'access', 'watch', and 'reserve' groups, aiming to balance their use based on infection burdens and resistance patterns. The framework, funded by the Wellcome Trust, highlights the overuse of 'watch' antibiotics, which contribute significantly to antibiotic resistance, and the underuse of 'access' and 'reserve' antibiotics in many countries. The study analyzed data from 186 countries, grouping them based on similar healthcare and socioeconomic characteristics to determine optimal antibiotic use. The findings suggest that many countries could improve antibiotic use by reducing unnecessary prescriptions and ensuring access to essential antibiotics.
AP News AP News
FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers

FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers

Federal health advisers are recommending broader access to controversial chemicals called peptides
AP News AP News
Kashmiri activist Khurram Parvez and journalist Irfan Mehraj freed on bail, under tight curbs

Kashmiri activist Khurram Parvez and journalist Irfan Mehraj freed on bail, under tight curbs

A prominent Kashmiri human rights activist and a renowned journalist have been released on bail after years of imprisonment on allegations of financing terrorism in the Indian-controlled portion of Kashmir
Rapid Read Rapid Read
Cold Spring Harbor Laboratory Scientists Revive Vancomycin to Combat Superbugs

Cold Spring Harbor Laboratory Scientists Revive Vancomycin to Combat Superbugs

Researchers at Cold Spring Harbor Laboratory (CSHL), led by Professor John Moses, have developed a method to restore the effectiveness of vancomycin, a powerful antibiotic that had become less effective against certain drug-resistant bacteria. The team utilized a technique called diversity oriented clicking (DOC) to create a library of over 150 compounds. In collaboration with Scripps Research, they identified a small molecule, pghi-4, which inhibits a bacterial enzyme called secreted antigen A (SagA). This inhibition allows vancomycin to regain its ability to kill drug-resistant strains of E. faecium, a pathogen known for causing severe infections. The research highlights the potential of using existing drugs in combination with new molecules to combat antibiotic resistance.
Rapid Read Rapid Read
FDA to Review Peptide Regulations Amid Safety Concerns

FDA to Review Peptide Regulations Amid Safety Concerns

The U.S. Food and Drug Administration (FDA) is set to convene a panel of outside experts to discuss whether compounding pharmacies should be allowed to produce certain injectable peptides. These peptides, including TB-500, BPC-157, and MOTs-C, are popular in the wellness industry for their purported benefits in muscle growth, fat loss, and skin health. However, none of these compounds have undergone large-scale trials to establish their safety and efficacy, raising concerns among scientists and regulators. The FDA's Pharmacy Compounding Advisory Committee will review the evidence for these peptides over a two-day meeting. The discussion comes amid a growing demand for peptides, which has led to a gray market of unregulated suppliers.
Rapid Read Rapid Read
FDA Panel Recommends Easing Access to Peptides Amid Safety Concerns

FDA Panel Recommends Easing Access to Peptides Amid Safety Concerns

An FDA advisory panel has narrowly recommended easing restrictions on several peptides, despite concerns from FDA scientists about their safety and efficacy. The panel voted 8-6 in favor of allowing pharmacies to compound peptides like BPC-157 and TB-500, which are popular among wellness influencers. The decision comes amid debates over the lack of human studies and potential risks associated with these substances. The FDA will review the panel's recommendations, which are not binding, before making a final decision. The outcome could impact the availability and regulation of peptides in the U.S.
Rapid Read Rapid Read
Fentanyl's Role in Overdose Crisis Highlights Need for Rehabilitation Programs

Fentanyl's Role in Overdose Crisis Highlights Need for Rehabilitation Programs

Fentanyl, a potent opioid, is increasingly recognized as a major contributor to overdose deaths globally. Originally prescribed for severe pain management, its misuse has led to widespread addiction and fatalities. The drug's potency, even in small doses, poses significant risks, making it difficult for individuals to overcome dependency without professional help. Get Help Global offers at-home rehabilitation services to support individuals in recovery, emphasizing the importance of professional treatment in a familiar environment. Ruben Mas, the founder of Get Help Global, stresses the importance of belief in change as a starting point for recovery.
Rapid Read Rapid Read
U.S. Faces Challenges in Maintaining Lead in Rare Disease Drug Development

U.S. Faces Challenges in Maintaining Lead in Rare Disease Drug Development

A report by the National Security Commission on Emerging Biotechnology warns that the U.S. is losing its lead in rare disease drug development, posing a national security risk. The report highlights China's rapid progress in biotech innovation, driven by accelerated clinical trial pathways and active participant recruitment. The U.S. government's current policies focus more on curbing Chinese influence rather than bolstering domestic drug development. However, initiatives like the FDA's pilot program to improve clinical trial protocols aim to expedite drug development. The report calls for supportive policies to maintain U.S. competitiveness in this critical sector.
Rapid Read Rapid Read
FDA Maintains Restrictions on Thymosin Alpha-1 Amid Safety Concerns

FDA Maintains Restrictions on Thymosin Alpha-1 Amid Safety Concerns

Thymosin Alpha-1, a peptide with potential immune-boosting properties, remains restricted by the FDA in the United States. Despite being approved in over 30 countries for conditions like viral hepatitis, the FDA has placed it on the Category 2 list, prohibiting its use in compounding by pharmacists. This decision stems from concerns about the peptide's stability during manufacturing and the potential for increased immunogenicity if used at higher concentrations than those tested in clinical trials. The peptide, which enhances antibody response and T-cell activity, has shown promise in treating immunocompromised individuals, including COVID long-haulers. However, the FDA cites inadequate safety data as a reason for its continued restriction.
Trendline Trendline
Creatine Supplementation: Potential Mental Health Benefits and Current Evidence

Creatine Supplementation: Potential Mental Health Benefits and Current Evidence

Creatine Supplementation: Potential Mental Health Benefits and Current Evidence
Reuters Reuters
Food, fury and supporters near and far keep India protest alive

Food, fury and supporters near and far keep India protest alive

By Tora Agarwala NEW DELHI, July 22 (Reuters) - A steady stream of food delivery riders carrying meals, snacks and bottled water is helping sustain a youth-led protest movement that has sprung up in the heart of India's capital.
Reuters Reuters
Analysis-India student protests give opposition a rare opening against Modi

Analysis-India student protests give opposition a rare opening against Modi

By Krishna N.